Avalo Therapeutics, Inc. · NASDAQ:AVTX

Millennium Management LLC reported a 5.00% stake in Avalo Therapeutics, Inc. (Schedule 13G)

Event Feb 17, 2026 · Filed Feb 24, 2026

Millennium Management LLC reported a 5.00% stake in Avalo Therapeutics, Inc., 934,429 shares, as a passive investor on Feb 17, 2026. Filed Feb 24, 2026 (Schedule 13G).

Stake
5.00%
Shares
934,429
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Millennium Management LLC5.00%934,429
Millennium Group Management LLC5.00%934,429
Israel A. Englander5.00%934,429

Source

View original at SEC

Related